Competent Cells Market Highly Favorable to the Growth Rate by 2022

A latest research study published by Future Market Insights (FMI) projects the global competent cells market to register an impressive 8.1% CAGR throughout the forecast period 2017 to 2022. The global market for competent cells is estimated to exceed US$ 2,000 Mn in revenues by 2022-end.

Competent Cells Available in the Market in Ready-to-use Formats

Preparations of competent cells, along with other methods of transformation, have been continuously improvised, since the development of E. coli’s artificial transformation with the help of electroporation and chemicals. Currently, various competent cells are available in the market in ready-to-use formats for propagating cloned plasmids in the experiments of molecular biology. These competent cells are prepared for different transformation procedures, genotypes, packaging, and transformation efficiencies.

With the advent of new technologies, several advancements have been witnessed in the molecular cloning research. Over the past few years, the recombinant proteins and molecular cloned products have experienced a robust commercial demand, thereby driving adoption of competent cells. However, adoption of competent cells is witnessing strong barriers on the back of increasing consolidation of the market, and huge cost of kits related to competent cells.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5061 

North America will Continue to be Largest Market for Competent Cells

In terms of revenues, North America is anticipated to remain the largest market for competent cells, with sales estimated to exceed US$ 750 Mn in revenues by 2022-end. Huge investments in research and development activities associated with competent cells is driving the market in North America. In addition, the market in Europe is estimated to create an absolute $ opportunity of nearly US$ 200 Mn between 2017 and 2022.

On the basis of product type, although chemically competent cells will continue to be sought-after in the market, sales of electrocompetent cells are projected to register a relatively faster expansion through 2022. Growing demand for electrocompetent cells can be mainly attributed to their provision of high transformation efficiencies, making them suitable for several molecular biology applications, for example – construction of gene banks, or, generation of cDNA libraries. Revenues from sales of electrocompetent cells are projected to account for nearly one-third share of the market over the forecast period.

Academic Research Institutes to Remain Largest End-users of Competent Cells

Academic research institutes are anticipated to remain the largest end-users of competent cells throughout the forecast period. Sales of competent cells in academic research institutes are projected to exhibit an impressive expansion to account for nearly half revenue share of the market during 2017 to 2022. However, sales of competent cells in pharmaceutical & biotechnology companies are expected to register the fastest expansion through 2022. Contract research organisations are expected to be the least lucrative end-users of competent cells in the global market.

Competent cells are expected to find the largest application in cloning during 2017 to 2022. Governments across the globe are providing tremendous support and funding for research and development activities associated with cloning. Revenues from sales of competent cells for application in cloning are estimated to account for over half revenue share of the market during the forecast period. Sales of competent cells for application in protein expression are expected to register the highest CAGR through 2022.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5061 

Leading Market Players focusing on Increasing their Product Portfolio

Global leading players in the competent cells market are focusing on increasing their product folio, in a bid to gain a competitive edge in the market. Key players listed in FMI’s report on the global competent cells market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Genescript Biotech Corporation, Illumina, Inc., Merck & Co. Inc., New England Biolabs Inc., OriGene Technologies, Inc., QIAGEN N.V., Thermo Fischer Scientific, Inc., and Zymo Research Corporation.

Neonatal Phototherapy Devices Market Rugged Expansion Foreseen by 2027

Neonatal jaundice is a major concern amongst new-borns and is a common cause of morbidity in the crucial first few months of life. Approx. 80% of preterm new-borns can suffer from neonatal jaundice making its effective treatment a critical health issue. Future Market Insights has conducted an exhaustive study on the neonatal phototherapy devices market in its upcoming report titled ‘Neonatal Phototherapy Devices Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’. The neonatal phototherapy devices market is anticipated to witness a CAGR of 5.3% for the period 2017-2027 and grow to more than US$ 140 million by then.

Product Type – Traditional Phototherapy Commonly Preferred by Hospitals

Traditional phototherapy devices are the most commonly used product type in the neonatal phototherapy devices market on account of their relative affordability – especially relevant in emerging economies. Traditional phototherapy devices have an improved lifespan and can easily be attached to an incubator. The National Institute of Health found that almost 15 million babies are born premature around the world with significantly increasing figures over the past few decades. This is the surest sign that the need for foetal, neonatal, and prenatal care equipment will skyrocket in the future, benefiting the neonatal phototherapy devices market.

A Sample of this Report is Available upon Request @ https://www.futuremarketinsights.com/reports/sample/REP-GB-5064

The development of advanced technologies in North America and Western Europe should propel the neonatal phototherapy devices market with a strong demand for products such as LED phototherapy units. Traditional phototherapy devices are primarily used by hospitals as they are easy to install, simple to use, and durable. Furthermore, the height of the phototherapy lamp can be easily adjusted. A number of non-profit organisations and large players in the neonatal phototherapy devices market are collaborating on the development of cost-effective phototherapy units that can treat neonatal jaundice at the minimal cost in emerging economies.

Product Type – Phototherapy Beds Better Suited to Home Care Settings

The phototherapy bed market is predicted to record a CAGR of 5.6% over the forecast period. Phototherapy beds are lightweight and portable and help maintain the vital bond between mothers and their babies. Phototherapy beds are efficient, low-cost, simple to use, and perfect in either home care or nursery ward settings.

Product Type – Flexible Phototherapy Devices Offer the Best of Both Worlds

Flexible phototherapy devices, as their name suggests, mould their shape according to that of the baby and are available in a range of sizes in the neonatal phototherapy devices market. Flexible phototherapy devices offer an extremely soothing healing environment for a new-born baby without hampering the benefits of Kangaroo Care (Mother – child bonding). The flexible phototherapy lamps market is projected to cross a value of US$ 11 million in 2017 alone.

Region – APAC to Grab Maximum Attention in the Neonatal Phototherapy Devices Market

Emerging markets i.e. APAC, Latin America, and the MEA region account for the lion’s share of the global population and have half the neonatal phototherapy devices market to themselves. The APAC region spearheaded by China and India is making significant effort in trying to leverage the existing opportunities in the neonatal phototherapy devices market. Key stakeholders in the neonatal phototherapy devices market are focusing their energy on these regions because of the high birth rate and rising prevalence of diseases that thereby drives the APAC neonatal phototherapy devices market.

Competition Dashboard in the Neonatal Phototherapy Devices Market

The companies profiled by Future Market Insights in the neonatal phototherapy devices market report include Natus Medical Incorporated, General Electric Company, Ibis Medical Equipment and Systems, Atom Medical Corporation, Medela AG, D-Rev, Phoenix Medical Systems, Zhengzhou Dison Instrument And Meter, Fanem, Drägerwerk AG & Co., Novos Medical Systems, Weyer GmbH, BabyBloom Healthcare BV, Medical Technology Transfer and Services Asia, Koninklijke Philips N.V., and Medical Technology Transfer and Services Asia.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5064 

Important Insights on the Neonatal Phototherapy Devices Market

Governments in several countries have begun programs that provide more facilities for new-born and childcare along with promotions through conferences and exhibitions. For e.g. – In African nations, communities have initiated programmes that have new-born health and safety as their primary objective.

Microscope Digital Cameras Market: Industry Trends and Developments 2017-2027

Valuable insights on the global scenario of microscope digital cameras have been presented systematically in a recently carried out research on microscope digital cameras market by Future market Insights in its new publication titled “Microscope Digital Cameras: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. This research focusses on key players, trends, growth drivers, opportunities, developments and restraints across several key geographies of North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA). On the basis of a structured research process and taking into consideration the past and present scenario, forecasts are provided in the research report from the period 2017 to 2027, a ten year forecast model, across each and every segment of the market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3523 

Global Microscope Digital Cameras Market: Forecast Highlights

According to the insightful market survey on microscope digital cameras, the global microscope digital cameras market is anticipated to grow at a high pace to register a robust 9.2% CAGR during the assessment period. During the 2017-2027 period, the global market is estimated to reach a market evaluation of about US$ 1.2 Bn by the end of 2027.

Global Microscope Digital Cameras Market: Segmental Insights

Global microscope digital cameras market is segmented by product type (biological microscope cameras, industrial microscope cameras), by sensor type (CMOS, CCD), by mount type (C mount, eyepiece mount/ocular mount), by end user (hospitals, research laboratories, pharmaceutical and biotechnology industries, clinics) and by region.

• North America region shows high lucrativeness and is expected to dominate the global microscope digital cameras market during the forecast period with respect to high market valuation. This region is estimated to grow at a stellar growth rate to reach a valuation of about US$ 353.3 Mn by 2027 end. Japan region is expected to grow at the highest rate, a shade higher than North America to register a 10.3% CAGR throughout the forecast period
• Biological microscope cameras segment by product type, is projected to register a higher CAGR of 9.3% during the forecast period and is more likely to lead the global market by product type in terms of high market value
• By mount type, C mount segment shows high potential as it grows at a comparatively high rate to reach a 9.4% CAGR and is likely to show dominance over eyepiece mount/ ocular mount segment. The C mount segment shows a market value almost seven times that of the eyepiece mount/ ocular mount segment
• The CCD segment by sensor type is expected to lead the market with a high value share. The CMOS segment shows high growth rate to register a stellar CAGR of 11.3% throughout the assessment period
• By end user, research laboratories (clinical and non-clinical) segment dominates the global market with a valuation of about US$ 645.7 Mn in 2027, growing at a robust growth rate. With respect to growth rate, the pharmaceutical and biotechnology industries segment is projected to register the highest CAGR of 9.7% during the period of forecast 2017-2027

Global Microscope Digital Cameras Market: Dynamics

Various factors favour the growth of the global microscope digital cameras market and the impact of these factors changes from region to region. Diverse application of microscope imaging technology, rising preference for CMOS and CCD, increasing penetration of international players through mergers, growing partnerships for direct distribution, higher spending on academic research along with focus on digital pathology, emergence of digitalization in the life science research, rising demand for microscopy cameras in scientific applications, new product innovations and launches, advancements in microscope digital cameras and rising laboratory automation are supporting the growth of the global microscope digital cameras market. However, factors such as premium pricing limiting market penetration ability, limited manufacturing facilities for microscope cameras, high equipment cost and entry barriers for small players to enter the consolidated market are posing growth restraints to the growth of the global microscope digital cameras market.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-3523 

Global Microscope Digital Cameras Market: Competition Analysis

The global microscope digital cameras market has profiled key players such as Danaher Corporation, Nikon Corporation, Roper Technologies, Inc., Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Basler AG, Guangzhou Micro-shot Technology Co., Ltd., BMS microscopes bv., and Euromex Microscopen bv.

Downstream Processing Market Size Projected to Rise Lucratively during 2017-2022

Downstream processing is used to manufacture antibiotics, antibodies, hormones, vaccines and also used for the production of industrial enzymes. In downstream processing, the purification and recovery of biosynthetic products is done that are derived from natural sources such as tissues of animals and plants. The growth of the downstream processing market is fuelled by the ever growing demand for biopharmaceuticals and increasing R&D spending on the development of such products. However, the high cost of the instruments involved in downstream processing and a dearth of skilled workforce is hampering the growth of this market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5070 

The global downstream processing market is slated to touch a value of about US$ 25,800 Mn in the year 2022 and display a robust CAGR during the assessment period.

4 Forecast Highlights on Global Downstream Processing Market

• As per the forecast of Future Market Insights, the filters product type segment is slated to touch a value of nearly US$ 5,700 Mn in the year 2022. This represents a robust CAGR during the assessment period of 2017-2022. The filters product type segment is estimated to account for more than one-fifth of the revenue share of the product type segment by the year 2017 and is forecasted to lose market share by 2022 over 2017.

• As per the forecast of Future Market Insights, the contract manufacturing organizations segment will reach a value of nearly US$ 5,500 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The contract manufacturing organizations segment is forecasted to account for more than one-third of the total revenue share of the end users segment by the end of the year 2017 and is expected to lose in market share by 2022 as compared with the year 2017.

• As per the forecast of Future Market Insights, the monoclonal antibody production segment is slated to reach a value of about US$ 8,300 Mn in 2022. The monoclonal antibody production segment is expected to gain market share by the end of the year 2022. The largest share is contributed by the North America region in the monoclonal antibody production segment.

• Future Market Insights forecasts the gel chromatography segment to exhibit a compound annual growth rate (CAGR) of nearly 15.0% from 2017 to 2022.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5070 

The report has also included the profiles of some of the leading companies in the downstream processing market like Sartorius Aktiengesellschaft, Repligen Corporation, Merck & Co Inc., Thermo Fisher Scientific, Inc., Eppendorf AG, General Electric Company, Corning Incorporated, 3M Company, Lonza Group Ltd. and Danaher Corporation.

Ambulatory Surgical Centres Market: Key Players, Growth, Analysis by 2017-2027

Future Market Insights delivers key insights and presents a revised forecast of the global ambulatory surgical centres market for a 10 year period from 2017 to 2027 in the report titled “Ambulatory Surgical Centres Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027.” The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of key market participants. The global ambulatory surgical centres market is projected to expand at a healthy CAGR of 4.0% in terms of value during the forecast period, revised from the previous CAGR of 3.9%, due to factors regarding which FMI offers useful insights in detail in this report.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5071 

The report broadly segments the global ambulatory surgical centres market on the basis of centre type, modality, services speciality area and region. Based on centre type, the global ambulatory surgical centres market has been segmented into single speciality centres and multispecialty centres.

Multispecialty Centres Segment is the Most Lucrative Segment

Multispecialty centres segment is estimated to dominate the ambulatory surgical centres market by product type with 65% value share of the market by 2017 end. Multispecialty centres segment is expected to reach US$ 76,028.6 Mn by 2027 end and will grow at the fastest CAGR of 4.4% over the forecast period.

Hospital-Based Ambulatory Surgical Centre Segment Accounts for Higher Market Demand

Among modality types, hospital-based ambulatory surgical centre segment is expected to dominate the global ambulatory surgical centres market with 59.5% value share in 2017. Hospital-based ambulatory surgical centre segment is expected to reach a market value of US$ 69,700.4 Mn by 2027 end, growing with a CAGR of 4.4% over the forecast period.

Surgical Services Segment Dominates by Service Type

Surgical services segment is estimated to dominate the global ambulatory surgical centres market by service type with higher value share of the market by 2017 end. Surgical services segment is expected to reach US$ 77,664.3 Mn by 2027 end and will grow at a CAGR of 4.2% over the forecast period.

Gastroenterology Segment is the Most Attractive Segment by Speciality Area

Among speciality areas, gastroenterology is expected to dominate the global ambulatory surgical centres market in terms of value share during the forecast period. Gastroenterology is expected to grow at a CAGR of 4.7% over the forecast period.

North America Will Continue to Grow at an Exponential Rate

FMI has analysed the ambulatory surgical centres market across seven key regions namely North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). North America is expected to dominate the market value share for ambulatory surgical centres and is expected to reach US$ 61,588.4 Mn by 2027 end. The Western Europe market is expected to account for the second largest market value share, followed by APEJ. North America and Europe are collectively expected to constitute more than 82% of the market share over the forecast period. MEA is predicted to be the least attractive region in the global ambulatory surgical centres market.

Key Insights from FMI’s Report on the Ambulatory Surgical Centres Market

• Growing focus on containment of healthcare costs and increased Medicare spending on ASCs are driving the global ambulatory surgical centre market.
• Number of outpatient surgeries have increased significantly in the recent years, thereby impacting the ambulatory surgical centres market worldwide. Also, a significant share of outpatient procedures have shifted from hospitals to free-standing ambulatory surgical facilities over the same period.
• Over the last decade, various constitutes across healthcare continuum, including private insurance companies, self-insured employers, and government payers, are implementing meaningful cost-containment measures.
• Leading manufacturers are focussing on setting up manufacturing facilities in emerging markets and this would substantially increase the chances of growth, as there would be no import-export glitches.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5071 

Ambulatory Surgical Centres Market: Key Players 

Key competitors covered in the report include AmSurg Corp., HCA Holdings, Inc., Tenet Healthcare, Surgical Care Affiliates, Inc., Ambulatory Surgical Centers of America, Surgery Partners, Medical Facilities Corporation, Healthway Medical Group and Community Health Systems, Inc.

Vascular Closure Device (VCD) Market: Value Chain, Dynamics and Key Players 2017 - 2022

Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade. With rising incidence of cardiac disorders, new and improved cardiovascular treatments have been developed, which have further propelled the adoption of vascular closure devices (VCDs). According to a recently-published market study by Future Market Insights, the global market for vascular closure devices will expand steadily at a CAGR of 5.9%, and reach US$ 963 million over the forecast period, 2017-2022. Compared to manual compression techniques, vascular closure devices play a key role in lowering undue complications such as bleeding.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1809 

However, increasing use of transradial arterial access, the continued requirement for post-procedure bed rest, significant costs, and device deployment complexities are observed as key deterrents for adoption of vascular closure devices. The use of VCDs is also anticipated to be influenced by a significant increase in the number of outpatient PCI procedures and the desire of patients to avoid arterial cut-down procedures. According to the report, hospitals will be the largest end-users of vascular closure devices in the next five years. By the end of 2022, over US$ 600 million revenues are anticipated to be procured globally from the end-use of vascular closure devices in hospitals.

Clip-based VCDs to Register 6% CAGR through 2022

A key insight from the report reveals that the demand for clip-based vascular closure devices will be relatively higher than compression devices and haemostasis pads. Despite the latter being top-selling products in the global vascular closure devices market, clip-based VCDs are expected to outpace them in terms of demand over the next five years. From medical standpoint, many surgeons prefer VCDs designed with active approximators that can physically close the arteriotomy by using nitinol clips. These metallic clips can also restrict MRI scanners from capturing the unnecessary structures which are immediately adjacent to the arteriotomy. These clip-based VCDs can boost procedural efficiency as well as post-procedural diagnostics for a wide range of cardiovascular treatments.

North America to Exhibit Steadfast Adoption of Vascular Closure Devices

A regional analysis provided in the report reveals North America as the largest market for vascular closure devices. The region is anticipated to remain at the forefront of global expansion of vascular closure devices market through 2022. Robust healthcare marketplaces in the US, coupled with consumer lifestyles that have surged the incidence of cardiac disorders, will continue to boost North America’s presence in the global vascular closure devices market. The report also projects that Asia-Pacific excluding Japan (APEJ) region will register fastest growth in its vascular closure devices market, and rake over US$ 145 million by the end of 2022.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-1809 

Companies to Watch

Companies namely, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc, Cardiva Medical, Inc., Arstasis, Inc., Chitogen, Inc., Marine Polymer Technologies, Inc., Essential Medical, Inc., Scion Cardio-Vascular, Inc., Morris Innovative, Inc., Tricol Biomedical, Inc., Vascular Closure Systems, Inc., and TZ Medical, Inc. are profiled in the report as key players in the global vascular closure devices market. In the near future, several manufacturers of vascular closure devices will be focusing on reducing the existing drawbacks of using VCDs, which include extended hospitalisation, high morbidity risks, and the need for administering antibiotics. Some companies will also be focusing on advancing their umbrella on VCD technologies and improving the quality of life for patients being treated through vascular closure devices.

Microbial Identification Market: Outlook Continues to Remain Positive by 2017 – 2022

Future Market Insights has recently published an exclusive forecast report on the global market for microbial identification. In the foreseeable future, improvements in techniques adopted by microbiologists for identifying pathogens and examining microbial cultures will factor developments in microbial identification systems. From healthcare to food & beverage, the vital use of microbial identification in applied research projects will continue to boost the growth of the global microbial identification market. By 2022-end, microbial identification systems are pegged to become a global market worth US$ 1.4 billion. During the forecast period, 2017-2022, the global market for microbial identification will be registering a robust growth at 6% CAGR. The report has analysed a slew of factors influencing the dynamics of microbial identification markets across several regions.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5077 

North America to register steadfast adoption of microbial identification

A key discernment from the regional analysis delivered in the report exhibits the dominance of North America in the global microbial identification market. Considering how healthcare marketplaces in the US and Canada are robust, compared to other developed markets, and taking into account the rising contribution of North American academic institutes in developing research studies of medical microbiology, the adoption of microbial identification systems will be widespread in this region. Towards the end of forecast period, North America’s microbial identification market will be worth around half a billion dollars, soaring robustly at a CAGR of 6.4%. Europe and Asia-Pacific excluding Japan (APEJ) will also be observed as lucrative markets for expansion of microbial identification.

Key Findings from the Report

• In 2017, over two-fifth of revenues anticipated to be procured in the global microbial identification market will be accounted by sales of bacterial identification systems
• Towards the end of forecast period, global sales of microbial remuneration systems will procure an estimated US$ 310 million in revenues
• Throughout the forecast period, bacterial resistance identification systems will represent the fastest-selling product in the overall microbial identification market
• Pharmaceuticals and biotechnology industry will remain the largest end-user of microbial identification by 2022
• The end-use of microbial identification systems in water and environment sector will remain steady in 2017 and the following years
• Between 2017 and 2022, the end-use of microbial identification across independent research laboratories in the world is anticipated to create an incremental opportunity of more than US$ 50 million
• In 2017 and beyond, the use of microbial identification methods in blood banks will be subpar
• Diagnostics remains to be a key application for microbial identification, revenues from which are anticipated to register above-average growth
• While detection of harmful microbes is viewed as a necessary measure for bolstering quality control in production of food items and drinks, the application of microbial identification in food & beverage testing will register a moderate CAGR in terms of revenues over the forecast period
• On the basis of technologies, phenotypic microbial identification methods are anticipated to remain predominant in terms of adoption, albeit, genotypic technologies will register a marginally high CAGR during the assessment period

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5077 

The report has further profiled companies that will be actively manufacturing microbial identification systems in the global market. Key players in the global microbial identification market include, Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Siemens Healthineers, QIAGEN N.V., Merck & Co Inc., bioMerieux S.A., Becton, Dickinson and Company, and Biolog, Inc. Many of these companies are expected to focus on developing microbial identification systems that befit the advancements in the field of medical microbiology. Specific requirements of microbiologist working in leading microbial identification projects will also influence the manufacturing techniques exercised by these companies.

Handheld Ultrasound Scanners Market Would Register a Healthy Growth Rate During Forecast 2017 - 2027

Future Market Insights has analysed various facets of the handheld ultrasound scanners market from a global standpoint and has skilfully presented them in its new research publication titled “Handheld Ultrasound Scanners Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. The comprehensive handheld ultrasound scanners market research report covers various trends, opportunities, drivers and restraints influencing the growth of the global handheld ultrasound scanners market along with regional analysis, competitive scenario and forecasts. This analysis focusses on each segment and sub-segment of the global market based on which analysts have given their opinions regarding various market dynamics.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5107 

Global Handheld Ultrasound Scanners Market: Forecast Insights

The global handheld ultrasound scanners market is projected to grow at a robust growth rate throughout the period of assessment. The global market is expected to grow at a value CAGR of 8.8% during 2017-2027 period to reach a market evaluation of about US$ 725 Mn by 2027 end from a value of around US$ 311 Mn in 2017. The growth path of the handheld ultrasound scanners market is steady since 2012, starting from a gradual increase to project at a robust growth rate during the assessment period.

Global Handheld Ultrasound Scanners Market: Dynamics        

Technological advancements in medical imaging devices, rising use of handheld ultrasound scanners among non-radiologists, advantages from international trade agreements, increased importing of imaging diagnostics systems, rising use of handheld ultrasound scanners in emergency medical services, rising healthcare expenditure, increasing medical device manufacturers, rising focus of healthcare companies on inorganic growth, innovations and developments in ultrasound scanning technology, modernization in healthcare investment, changing healthcare pattern, increasing prevalence of chronic disorders and adoption of distribution and licensing agreements by various players to increase product penetration are few factors which fuel the growth of the global handheld ultrasound scanners market. However, aspects such as limited research and development in certain areas, rising consumption tax, lack of skilled professionals, non-standardized product prising and counterfeiting of medical devices pose restraints to the growth of the global handheld ultrasound scanners market.

Global Handheld Ultrasound Scanners Market: Segmental Highlights

The global handheld ultrasound scanners market is segmented by end user (hospitals, diagnostic centres, ASCs and others), modality type (wired scanners and wireless scanners), display type (black and white display and colour display) and region (North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East and Africa).

• North America region to dominate the global market and projected to grow at the highest CAGR of 9.5% throughout the period of assessment. This region is estimated to show a value more than US$ 330 Mn by the end of 2027. Following North America, comes Asia Pacific excluding Japan region, which stands second with respect to market valuation during 2017-2027
• By display type, the colour display segment is highly lucrative as it reflects a higher market growth to register a CAGR of 9.5% to reach an evaluation of about US$ 460 Mn by the end of 2027. It also shows high market attractiveness index of 1.3 over the forecast period
• By modality type, wireless scanners segment is poised to be the fastest growing segment as it portrays a CAGR of 10.1% during the period of assessment. However, the wired scanners segment is expected to lead the global market with a high market value by the end of the forecast period
• Hospitals segment by end user is the most lucrative segment for the growth of the handheld ultrasound scanners market. This segment is poised to register a high CAGR of 9.3% during 2017-2027 to reach a a high market value of US$ 280 Mn by the end of 2027

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5107 

Global Handheld Ultrasound Scanners Market: Competition Analysis

The global handheld ultrasound scanners market research report includes company profiles of key players involved in the daily operations of handheld ultrasound scanners. Koninklijke Philips N.V., GE Healthcare, Fujifilm SonoSite, Inc., Clarius Mobile Health, Signostics Limited, Sonoscanner SARL, Mobisante, Inc., Terason (Teratech corp.), Shenzhen Sunway Medical Device Co., Ltd., Shenzhen WELLD Medical Electronics Co., Ltd., Shenzhen Landwind Industry Co., Ltd., Healcerion, Co., Ltd., Meditech Equipment Co.,Ltd (Meditech Group), Sino-Hero(Shenzhen) Bio-Medical Electronics Co., Ltd., Caresono Technology CO., Ltd., Sonostar Technologies Co., Ltd., DGH Technology, Inc., and Xuzhou Palmary Electronics Co., Ltd., are the key players analysed in the global handheld ultrasound scanners market research study.

Laser Therapy Devices Market to Register Steady Expansion During 2017-2022

In the field of medical science, lasers are used in specific wavelengths of light, from red to near infrared, in order to create beneficial and therapeutic effects. Such kind of results include improved time of healing, reduction in pain, increased blood circulation and a reduction in swelling. A trend in the laser therapy devices market includes a shift towards pain-free and non-invasive procedures. The procedures related to medical aesthetics, both invasive and non-invasive, are becoming increasingly popular amongst the younger population. These procedures using lasers have replaced the traditional surgery and they give superior results with minimum complications. Moreover, non-invasive laser procedures like removal of scars, resurfacing of the skin, facelifts, laser hair removal and liposuction are becoming increasingly popular as they promote a younger looking appearance with minimal side effects.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5241 

The global laser therapy devices market is slated to touch a value of about US$ 1,900 Mn in the year 2022 and display a moderate CAGR during the assessment period.

4 Forecast Highlights on Global Laser therapy devices Market

• As per the forecast of Future Market Insights, the gas laser segment is slated to touch a value of more than US$ 470 Mn in the year 2022. This represents a robust CAGR during the assessment period of 2017-2022. The gas laser segment is estimated to account for nearly one-fourth of the revenue share of the device type segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.
• As per the forecast of Future Market Insights, the specialized clinics segment will reach a value of about US$ 825 Mn in the year 2017. This represents a moderate CAGR growth during the forecast period. The specialized clinics segment is forecasted to account for more than half of the total revenue share of the end user segment by the end of the year 2017 and is expected to gain in market share by 2022 as compared with the year 2017.
• As per the forecast of Future Market Insights, the ophthalmology segment is slated to reach a value of more than US$ 560 Mn in 2022. The ophthalmology segment is expected to gain market share by the end of the year 2022. The largest share is contributed by the North America region in the ophthalmology segment.
• Future Market Insights forecasts the United States laser therapy devices market to exhibit a compound annual growth rate (CAGR) of more than 4% from 2017 to 2022.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5241 

The report has also included the profiles of some of the leading companies in the laser therapy devices market like Thermo Fisher Scientific, Inc., Lumenis Ltd., Boston Scientific Corporation, Danaher Corporation, IPG Photonics Corporation, Alma Lasers, Ltd., Coherent, Inc., Fotona d.d., Biolitec AG and Hologic Inc.

Spinal Fusion Market is Expecting Worldwide Growth by 2027

Future Market Insights (FMI) delivers key insights on the global spinal fusion market in its upcoming report titled “Spinal Fusion Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017 – 2027.” In terms of revenue, the global spinal fusion market is projected to register a CAGR of 5.4% over the forecast period, owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. A key trend witnessed in the global spinal fusion market is the rise in the development of minimising load due to increasing adverse reactions. Furthermore, the growing importance of developing advanced products among big players to enhance their product portfolio is another key trend in the global spinal fusion market.

A Sample of this Report is Available upon Request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5259

Market Segmentation and Forecast

The global spinal fusion market is segmented based on product type, procedure type, end user and region. Based on product type, the market is segmented into interbody cages, pedicle screws and rods, and spinal fusion plates. Interbody cages is predicted to be the leading product type segment in the global spinal fusion market over the forecast period. Attenuated interbody cages segment will represent major revenue share of the global spinal fusion market in 2017.  By procedure, the global spinal fusion market is segmented into posterolateral fusion and interbody fusion. Interbody fusion is the leading segment in the global spinal fusion market over the forecast period. By end user, the global spinal fusion market is segmented into hospitals, speciality clinics and ambulatory surgical centres. Hospitals is the leading segment in the global spinal fusion market over the forecast period. Demand for spinal fusion is expected to be the highest in ambulatory surgical centres, which is expected to register a CAGR of 6.6 % over the forecast period.

This report assesses the trends that are driving the growth of each segment at the global as well as regional level, and offers potential takeaways that could prove substantially useful to manufacturers looking to enter the market. North America is expected to gain popularity over the forecast period, driven by increasing prevalence of spinal injuries across the region. The North America regional market is projected to dominate the global spinal fusion market, accounting for a maximum revenue share of the global market by 2017 end. The markets in North America, Western Europe, and Asia Pacific are collectively expected to account for around 68.6% of the global spinal fusion market value share by 2017 end. Revenue from the market in APEJ is estimated to expand at a CAGR of 8.9% over the forecast period.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5259

Key Players

Some of the leading market players covered in the report include Zimmer Biomet Holdings. Inc., K2M, Inc., MicroPort Scientific Corporation, Medtronic Plc., Johnson and Johnson (DePuy Synthes), Stryker Corporation, Integra Lifesciences Holdings Corp, Orthofix Holdings, Inc., Shandong Weigao Group Medical Polymer Company Limited, Bonovo Orthopedics, Inc., Suzhou Gemmed Medical Instrument Co. Ltd, NuVasive, Inc., B. Braun Melsungen AG, Globus Medical Inc., RTI Surgical, Inc., Expanding Orthopedics Inc., Vallum Corporation, ChoiceSpine, LP, Life Spine, Inc, and Precision Spine, Inc. In this report, we have discussed the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

DNA Polymerase Market- Global Industry Analysis by 2027

Future Market Insights presents a detailed forecast and in-depth insights on the global DNA polymerase market in a new report titled ‘DNA Polymerase Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027).’ According to the report, the global DNA polymerase market is anticipated to record a compounded annual growth rate of 6.5% and reach a market value of US$ 389.4 Mn in 2027.

Factors Impacting Market Revenue Growth

Staggering increase in the use of DNA polymerases in point-of-care and molecular diagnostics kits is expected to continue to influence the adoption of DNA polymerases. Increasing use of DNA polymerases in epigenetics research, in addition to the increasing investments in life sciences R&D is also expected to boost revenue growth of the global market. However, high cost of reagents and availability of alternative techniques are expected to limit market growth over the forecast period.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-801 

Global DNA Polymerase Market: Segmental Analysis & Forecast

By product type, growth of the eukaryotic DNA polymerase segment will be positively impacted by the introduction of various innovative products such as high-fidelity DNA polymerase that show excellent results in whole blood and other samples containing crude lysates. These products have been used in direct PCR applications, with limited sample processing, which have been a constant requirement especially for high throughput applications. In addition, the use of PCR-based technologies in point-of-care tests, companion diagnostics and other applications have led to a major boost for the DNA polymerase market. Manufacturers of DNA polymerases are entering into distribution agreements to extend product reach and collaborations to ensure they gain market share and remain competitive in global markets. Eukaryotic DNA polymerase segment is expected to hold the highest share of the market, as well as display strong growth, expanding at a CAGR of 6.7% over the forecast period. Among end use segments, molecular diagnostics companies are expected to hold the largest share of the global DNA polymerase market at over 31% market share in terms of revenue in 2027. However, the academic and research institutes segment is anticipated to expand at a robust growth rate of 7.4% over the forecast period.

Global DNA Polymerase Market: Regional Analysis & Forecast

FMI’s report segments the global DNA polymerase market on the basis of region into North America, Western Europe, Eastern Europe, Latin America, Asia Pacific Excluding Japan, Japan, and the Middle East & Africa. This report assesses key trends driving each market segment and offers analysis and insights on the DNA polymerase market across specific regions. The market in North America is anticipated to dominate the global DNA polymerase market with maximum value share by end of 2027, accounting for over 56% in terms of revenue. In terms of value, the market in Latin America is expected to be the fastest growing, registering a CAGR of 7.8% over the forecast period. The market in Asia Pacific Excluding Japan is also expected to show a significant growth of 7.7% over the forecast period.

Read Comprehensive Overview with Methodology of Report @ https://www.futuremarketinsights.com/askus/rep-gb-801 

Global DNA Polymerase Market: Vendor Landscape

Some of the key competitors covered in this report include Thermo Fisher Scientific Inc, Roche Diagnostics, Agilent Technologies, Qiagen NV, Takara Bio Company, Merck KGaA, Genscript, Illumina, New England Biolabs, and Promega Corporation. These vendors in the global DNA polymerase market are expanding their business by launching new and innovative products tailored for both research and in-vitro applications. Companies are also focussing on emerging markets in Asia Pacific to increase their geographical presence and tap into various end use segments that have the ability to invest in R&D for life sciences as well as develop innovative diagnostics tools.

Wound Irrigation Systems Market Healthy Pace throughout the Forecast during 2017 - 2027

The report on the global wound irrigation systems market covers annual sales revenue generated by various market segments during the period of assessment 2017-2027. Furthermore, developments taking place in the market, various trends impacting the market and other drivers fuelling the growth of the global wound irrigation systems market are enumerated in this research. Also few challenges that are pulling market growth southward are also assessed. The research report titled “Wound Irrigation Systems Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” presents a complete high level overview of the market to the reader and supports strategic plans for future moves by portraying an accurate forecast model of the global wound irrigation systems market.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3775 

Global Market Study on Wound Irrigation Systems: Factors Impacting Revenue Growth of the Global Market

There are various aspects influencing the growth of the global wound irrigation systems market in a positive as well as in a negative manner. Factors such as increasing initiatives by healthcare facilities, availability of improved product lines for wound care, increasing prevalence of chronic wounds and increasing adoption of advanced wound care products are pushing the growth of the global market for wound irrigation systems. Factors such as relatively higher costs associated with advanced wound care products and limited awareness among the rural population are hindering the growth of the global wound irrigation systems market. The market has also witnessed few trends that are likely to define the market’s growth in the coming years. Increasing acceptance of standardised protocols to manage complex wounds and collaborative agreements between manufacturers and channel partners are few of the trends that are contributing to the growth of the global wound irrigation systems market.

Global Market Study on Wound Irrigation Systems: Forecast Analysis

The global wound irrigation systems market is expected to grow at a slow rate to register a CAGR of 3.0% throughout the period of assessment and reach a valuation of more than US$ 300 Mn by the end of the year of assessment from a value of about US$ 230 Mn in 2017.

Global Market Study on Wound Irrigation Systems: Segmental Snapshot

The global wound irrigation systems market is segmented by product type, by wound type, by end user and by region.

• By product type, the battery operated segment is the largest with a high market valuation. The manually operated segment, however, is gaining traction and is poised to grow at a comparatively high CAGR throughout the period of forecast
• By wound type, the chronic wounds segment is projected to grow at a high CAGR of 3.5% during the forecast period. The acute wounds segment is likely to dominate the global market
• By end user, the home care centres segment is expected to grow at the fastest pace to reach a CAGR of 4.7% during the forecast period
• By region, North America is anticipated to radiate high market attractiveness throughout the forecast period. The wound irrigation systems market in Asia Pacific excluding Japan is projected to grow at a comparatively high rate during 2017-2027

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-3775 

Global Market Study on Wound Irrigation Systems: Competitive Scenario

The research report on the global wound irrigation systems market covers in-depth analysis on various key players participating in the market. Company overview, SWOT analysis, product portfolio, key developments and various growth strategies of major companies such as Zimmer Biomet, Stryker Corporation, Centurion Medical Products, BSN Medical, Cooper Surgical Inc., C. R. Bard, Inc., Medtronic Plc., Bionix, and Westmed, Inc.